Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
The Tissue-Engineered Vascular Graft—Past, Present, and Future
2015 Standout
“Intermittent claudication a real pain in the calf”—Patient experience of diagnosis and treatment with a supervised exercise program
2017 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Quality of life in patients with intermittent claudication
2017 StandoutNobel
A Systematic Review of the Uptake and Adherence Rates to Supervised Exercise Programs in Patients with Intermittent Claudication
2016 StandoutNobel
Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
2001 Standout
Medical Treatment of Peripheral Arterial Disease and Claudication
2001
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
2004
Safety of supervised exercise therapy in patients with intermittent claudication
2014
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Emerging drugs for diabetic foot ulcers
2006
Erectile Dysfunction
2000 Standout
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Exercise Standards for Testing and Training
2013 Standout
Preventing and treating foot complications associated with diabetes mellitus
2015
Disease-specific quality of life assessment in intermittent claudication: Review
2003
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
1998
Pharmacotherapy for critical limb ischaemia
2000
Effect of garlic on cardiovascular disorders: a review
2002 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Desmopressin in inherited disorders of platelet function
2007
Cardiovascular and musculoskeletal response to supervised exercise in patients with intermittent claudication
2018 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization
2015 StandoutNobel
Exercise Therapy or Angioplasty? A Summation Analysis
2000
ROS-scavenging hydrogel to promote healing of bacteria infected diabetic wounds
2020 Standout
Diabetes and Atherosclerosis
2002 Standout
Extracorporeal Shockwave Therapy for Peripheral Arterial Disease: A Review of the Potential Mechanisms of Action
2017 StandoutNobel
Prevention of Venous Thromboembolism
2004 Standout
Oral Beraprost Sodium, a Prostaglandin I 2 Analogue, for Intermittent Claudication
2000
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
2001
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack
1993
A systematic review of muscle morphology and function in intermittent claudication
2017 StandoutNobel
Treatment of Intermittent Claudication With Physical Training, Smoking Cessation, Pentoxifylline, or Nafronyl
1999
New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies
2004
Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: A randomized controlled trial
2011
A Systematic Review of Extracorporeal Shockwave Therapy as a Novel Treatment for Intermittent Claudication
2016 StandoutNobel
Trans-Atlantic Conference on Clinical Trial Guidelines in PAOD (Peripheral Arterial Occlusive Disease) Clinical Trial Methodology
1999
Management of Abdominal Aortic Aneurysms Clinical Practice Guidelines of the European Society for Vascular Surgery
2011 Standout
Atmospheric pressure plasmas: A review
2005 Standout
Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease
2016 StandoutNobel
Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar®
2000
Update on management of diabetic foot ulcers
2018 Standout
The Effect of Ciprostene in Patients with Peripheral Vascular Disease (PVD) Characterized by Ischemic Ulcers
1991
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Exercise for intermittent claudication
2014
The Rationale for Prostaglandin E1 in Erectile Failure: A Survey of Worldwide Experience
1996
Current and Future Drug Therapies for Claudication
1997
Plasma medicine: an introductory review
2009 Standout
Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
1996
Treatment of Lower Limb Ischaemia Due to Atherosclerosis in Diabetic and Nondiabetic Patients with Iloprost, a Stable Analogue of Prostacyclin
1991
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Prostanoids for critical limb ischaemia
2018
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Micro-structured electrode arrays: atmospheric pressure plasma processes and applications
2003
Supervised Exercise in Intermittent Claudication: A Sedentary Notion?
2009
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Impact of a 4-Week Treatment with Prostaglandin E1 on Health-Related Quality of Life of Patients with Intermittent Claudication
2000
Exercise for intermittent claudication
2017
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Access to supervised exercise services for peripheral vascular disease patients
2017 StandoutNobel
A micro plasma reactor for fluorinated waste gas treatment
2004
Prospective study of 713 below–knee amputations for ischaemia and the effect of a prostacyclin analogue on healing
1994
Works of P Scheffler being referenced
Gray platelet syndrome: Selective ?-granule deficiency and thrombocytopenia due to increased platelet turnover
1985
Treadmill testing for evaluation of claudication: Comparison of constant-load and graded-exercise tests
1997
Iloprost, ein stabiles Prostacyclinderivat, bei arterieller Verschlußkrankheit im Stadium IV: Eine placebo-kontrollierte Multizenterstudie
2008
Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: Results of a multicenter placebo-controlled double-blind trial
1997
[Cardiopulmonary effects of prostaglandin E1. Aspects of drug safety].
1992
[Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative].
1990
[The effectiveness of standardized exercise training in intermittent claudication].
1994
Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training.
1994
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudication.
1997
[Controlled vascular training in IIb peripheral arterial occlusive disease: additive effect of intravenous PGE1 versus intravenous pentoxifylline during training].
1991
Microstructure electrodes as a means of creating uniform discharges at atmospheric pressure
2002
Coincidence of risk factors and early carotid lesions, detected with modern ultrasound techniques.
1990